Clinical Trial

Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study

Recruiting
View on ClinicalTrials.gov →
Summary
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-20; most recent amendment 2025-07-03.
Trial Details
NCT Number NCT07043686
Lead Sponsor University Medical Centre Ljubljana
Conditions Ischemic Stroke, Acute, Rehabilitation Outcome, Cerebrolysin
Enrollment 30 participants
Start Date 2025-06-13
Primary Completion 2027-07-15 (estimated)
Study Completion 2027-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-09